Anjali S Advani1. Show Affiliations » 1. Cleveland Clinic Lerner College of Medicine, Department of Hematologic Oncology and Blood Disorders, The Cleveland Clinic, Cleveland, Ohio, USA.
Abstract
Entities: Chemical Disease Species
Mesh： See more » Antibodies, Bispecific/administration & dosageAntibodies, Bispecific/immunologyAntibodies, Bispecific/therapeutic useAntigens, CD19/immunologyAntineoplastic Agents/administration & dosageAntineoplastic Agents/immunologyAntineoplastic Agents/therapeutic useApoptosisCD3 Complex/immunologyClinical Trials as TopicDisease-Free SurvivalFlow CytometryHematopoietic Stem Cell TransplantationHumansImmunophenotypingLymphocyte ActivationNeoplasm, Residual/drug therapyNeoplasm, Residual/immunologyNeoplasm, Residual/mortalityPolymerase Chain ReactionPrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyPrecursor Cell Lymphoblastic Leukemia-Lymphoma/immunologyPrecursor Cell Lymphoblastic Leukemia-Lymphoma/mortalitySecondary PreventionT-Lymphocytes/drug effectsT-Lymphocytes/enzymology
Substances： See more » Antibodies, BispecificAntigens, CD19Antineoplastic AgentsCD3 Complexblinatumomab
Year: 2011 PMID： 22252580
Source DB: PubMed Journal: Clin Adv Hematol Oncol ISSN： 1543-0790